NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
10KSB, EX-27, 2000-09-28
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, 10KSB, EX-23, 2000-09-28
Next: GARDEN STATE NEWSPAPERS INC, 10-K405, 2000-09-28



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BALANCE SHEET
AND  INCOME  STATEMENTS  DATED  6/30/00  AND IS  QUALIFIED  IN ITS  ENTIRETY  BY
REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                               JUN-30-2000
<PERIOD-START>                                  JUL-01-1999
<PERIOD-END>                                    JUN-30-2000
<CASH>                                            7,387,076
<SECURITIES>                                      1,225,592
<RECEIVABLES>                                             0
<ALLOWANCES>                                              0
<INVENTORY>                                               0
<CURRENT-ASSETS>                                  8,654,965
<PP&E>                                              322,182
<DEPRECIATION>                                      294,404
<TOTAL-ASSETS>                                    8,682,743
<CURRENT-LIABILITIES>                               769,393
<BONDS>                                                   0
                                     0
                                       1,141,000
<COMMON>                                         42,170,818
<OTHER-SE>                                      (35,398,468)
<TOTAL-LIABILITY-AND-EQUITY>                      8,682,743
<SALES>                                                   0
<TOTAL-REVENUES>                                          0
<CGS>                                                     0
<TOTAL-COSTS>                                             0
<OTHER-EXPENSES>                                  3,275,731
<LOSS-PROVISION>                                          0
<INTEREST-EXPENSE>                                 (160,999)
<INCOME-PRETAX>                                  (3,114,732)
<INCOME-TAX>                                              0
<INCOME-CONTINUING>                              (3,114,732)
<DISCONTINUED>                                            0
<EXTRAORDINARY>                                           0
<CHANGES>                                                 0
<NET-INCOME>                                     (3,114,732)
<EPS-BASIC>                                           (0.27)
<EPS-DILUTED>                                         (0.27)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission